Blood-derived biomarkers for brain and spinal cord diseases are urgently needed. The
introduction of highly sensitive immunoassays led to a rapid increase in the number of potential …

In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers
of neurodegenerative dementias, enormous advancement has taken place in the field, …

Objective To examine neurofilament (Nf) concentrations according to symptom onset and
clinical diagnostic certainty categories of amyotrophic lateral sclerosis (ALS). Methods We …

Reliable blood biomarkers for Alzheimer’s disease (AD) are missing. We measured astroglial
GFAP in patients with AD (n= 28), frontotemporal dementia (bvFTD, n= 35), Parkinson’s …

Background In neurodegenerative dementias (NDs) such as prion disease, Alzheimer’s
disease (AD), and frontotemporal lobar degeneration (FTLD), protein misfolding leads to the …

Objectives Biomarkers for the diagnosis of motoneuron diseases (MND) are urgently needed
to improve the diagnostic pathway, patient stratification and monitoring. The aim of this …

Neurofilaments are elevated in the cerebrospinal fluid (CSF) and serum of amyotrophic lateral
sclerosis (ALS) patients. However, timing of this increase is unknown. To characterize the …

Objective To determine the diagnostic and prognostic performance of serum neurofilament
light chain (NFL) in amyotrophic lateral sclerosis (ALS). Methods This single-centre, …

Huntingtin (HTT) is a large (348 kDa) protein that is essential for embryonic development and
is involved in diverse cellular activities such as vesicular transport, endocytosis, autophagy …

Accurate patient stratification into prognostic categories and targeting Amyotrophic Lateral
Sclerosis (ALS)-associated pathways may pave the way for promising trials. We evaluated …